Skip to Main Content

Paper Details

<i>CKM</i> Glu83Gly Is Associated With Blunted Creatine Kinase Variation, but Not With Myalgia.
Circ Cardiovasc Genet
4
2017
CK, CKM, CKM Glu83Gly, Creatine, Creatine Kinase, Glu83Gly, Myalgia, Rosuvastatin, Statins, creatine, creatine kinase, creatine kinase (CK) muscle gene, creatine phosphokinase, minor, minor allele, muscle, muscle damage, myalgia, rs11559024
Author NameAffiliation
Moneeza K SiddiquiFrom the Pat McPherson Centre for Pharmacogenetics and Pharmacogenomics, Division of Molecular and Clinical Medicine, Ninewells Hospital and Medical School, University of Dundee, University of Edinburgh, United Kingdom Institute of Translational Medicine, University of Liverpool, Uppsala University, Utrecht University, Academic Medical Center, University of Amsterdam, The Netherlands (A.H.M.v.d.Z.) Brigham and Women's Hospital and Harvard Medical School
Abirami VeluchamyFrom the Pat McPherson Centre for Pharmacogenetics and Pharmacogenomics, Division of Molecular and Clinical Medicine, Ninewells Hospital and Medical School, University of Dundee, University of Edinburgh, United Kingdom Institute of Translational Medicine, University of Liverpool, Uppsala University, Utrecht University, Academic Medical Center, University of Amsterdam, The Netherlands (A.H.M.v.d.Z.) Brigham and Women's Hospital and Harvard Medical School
Andrew D MorrisFrom the Pat McPherson Centre for Pharmacogenetics and Pharmacogenomics, Division of Molecular and Clinical Medicine, Ninewells Hospital and Medical School, University of Dundee, University of Edinburgh, United Kingdom Institute of Translational Medicine, University of Liverpool, Uppsala University, Utrecht University, Academic Medical Center, University of Amsterdam, The Netherlands (A.H.M.v.d.Z.) Brigham and Women's Hospital and Harvard Medical School
Andrew D MorrisFrom the Pat McPherson Centre for Pharmacogenetics and Pharmacogenomics, Division of Molecular and Clinical Medicine, Ninewells Hospital and Medical School, University of Dundee, University of Edinburgh, United Kingdom Institute of Translational Medicine, University of Liverpool, Uppsala University, Utrecht University, Academic Medical Center, University of Amsterdam, The Netherlands (A.H.M.v.d.Z.) Brigham and Women's Hospital and Harvard Medical School
Alex S F DoneyFrom the Pat McPherson Centre for Pharmacogenetics and Pharmacogenomics, Division of Molecular and Clinical Medicine, Ninewells Hospital and Medical School, University of Dundee, University of Edinburgh, United Kingdom Institute of Translational Medicine, University of Liverpool, Uppsala University, Utrecht University, Academic Medical Center, University of Amsterdam, The Netherlands (A.H.M.v.d.Z.) Brigham and Women's Hospital and Harvard Medical School
Alex S F DoneyFrom the Pat McPherson Centre for Pharmacogenetics and Pharmacogenomics, Division of Molecular and Clinical Medicine, Ninewells Hospital and Medical School, University of Dundee, University of Edinburgh, United Kingdom Institute of Translational Medicine, University of Liverpool, Uppsala University, Utrecht University, Academic Medical Center, University of Amsterdam, The Netherlands (A.H.M.v.d.Z.) Brigham and Women's Hospital and Harvard Medical School
Anke H Maitland-van der ZeeFrom the Pat McPherson Centre for Pharmacogenetics and Pharmacogenomics, Division of Molecular and Clinical Medicine, Ninewells Hospital and Medical School, University of Dundee, University of Edinburgh, United Kingdom Institute of Translational Medicine, University of Liverpool, Uppsala University, Utrecht University, Academic Medical Center, University of Amsterdam, The Netherlands (A.H.M.v.d.Z.) Brigham and Women's Hospital and Harvard Medical School
Paul M RidkerFrom the Pat McPherson Centre for Pharmacogenetics and Pharmacogenomics, Division of Molecular and Clinical Medicine, Ninewells Hospital and Medical School, University of Dundee, University of Edinburgh, United Kingdom Institute of Translational Medicine, University of Liverpool, Uppsala University, Utrecht University, Academic Medical Center, University of Amsterdam, The Netherlands (A.H.M.v.d.Z.) Brigham and Women's Hospital and Harvard Medical School
Daniel I ChasmanFrom the Pat McPherson Centre for Pharmacogenetics and Pharmacogenomics, Division of Molecular and Clinical Medicine, Ninewells Hospital and Medical School, University of Dundee, University of Edinburgh, United Kingdom Institute of Translational Medicine, University of Liverpool, Uppsala University, Utrecht University, Academic Medical Center, University of Amsterdam, The Netherlands (A.H.M.v.d.Z.) Brigham and Women's Hospital and Harvard Medical School
Daniel I ChasmanFrom the Pat McPherson Centre for Pharmacogenetics and Pharmacogenomics, Division of Molecular and Clinical Medicine, Ninewells Hospital and Medical School, University of Dundee, University of Edinburgh, United Kingdom Institute of Translational Medicine, University of Liverpool, Uppsala University, Utrecht University, Academic Medical Center, University of Amsterdam, The Netherlands (A.H.M.v.d.Z.) Brigham and Women's Hospital and Harvard Medical School
Colin N A PalmerFrom the Pat McPherson Centre for Pharmacogenetics and Pharmacogenomics, Division of Molecular and Clinical Medicine, Ninewells Hospital and Medical School, University of Dundee, University of Edinburgh, United Kingdom Institute of Translational Medicine, University of Liverpool, Uppsala University, Utrecht University, Academic Medical Center, University of Amsterdam, The Netherlands (A.H.M.v.d.Z.) Brigham and Women's Hospital and Harvard Medical School
Colin N A PalmerFrom the Pat McPherson Centre for Pharmacogenetics and Pharmacogenomics, Division of Molecular and Clinical Medicine, Ninewells Hospital and Medical School, University of Dundee, University of Edinburgh, United Kingdom Institute of Translational Medicine, University of Liverpool, Uppsala University, Utrecht University, Academic Medical Center, University of Amsterdam, The Netherlands (A.H.M.v.d.Z.) Brigham and Women's Hospital and Harvard Medical School
  • 1 - 12

Datasets